US 11840688
Compositions and methods for inhibiting gene expression of Hif2alpha
granted A61KA61K31/713A61K45/06
Quick answer
US patent 11840688 (Compositions and methods for inhibiting gene expression of Hif2alpha) held by Arrowhead Pharmaceuticals, Inc. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713, A61K45/06, A61K47/60, A61K47/64